Iridex (IRIX) Interest & Investment Income (2010 - 2011)

Iridex (IRIX) recorded quarterly Interest & Investment Income of -$247000.0 in Q4 2011, down 88.55% quarter-over-quarter from -$131000.0 in Q4 2011.

Iridex (IRIX) Interest & Investment Income (2010 - 2011) Analysis & Trends

Iridex's Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$247000.0 for Q4 2011.

In Q4 2011, Interest & Investment Income changed N/A year-over-year to -$247000.0; the TTM figure through Dec 2011 stood at -$468000.0 (changed N/A YoY), while the FY2015 annual figure was -$1.3 million, down 238.27% from the prior year.
Interest & Investment Income was -$247000.0 for Q4 2011 at Iridex, down from -$131000.0 in the prior quarter.
In the past five years, Interest & Investment Income ranged from a high of $63000.0 in Q4 2010 to a low of -$247000.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	106.00 Mn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	-
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	-
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	-
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	33.50 Mn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	-
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	40.98 Mn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	-
10	Iridex	19.39 Mn	14.79 Mn	4.74 Mn	-

Download Data